Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Market Report, "Acorda Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report", published


Print article Print article
2013-12-04 13:23:27 - Fast Market Research recommends "Acorda Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report" from MarketLine, now available

Acorda Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Acorda Therapeutics, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Acorda Therapeutics, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Acorda Therapeutics, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Acorda Therapeutics, Inc.
* Intelligence on Acorda Therapeutics, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Acorda Therapeutics, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/737349_acorda_therapeutics_inc_swot_strategy ..

Highlights:

Acorda Therapeutics (Acorda or 'the company') is a commercial-stage biotechnology company engaged in the development and marketing of therapies to help restore function in persons with spinal cord injury, multiple sclerosis and related conditions of the central nervous system. Acorda's marketed products include Ampyra/Fampyra (dalfampridine) and Zanaflex capsules and tablets (tizanidine hydrochloride). The company primarily operates in the US, where it is headquartered in Ardsley, New York, and employed 378 people as of February 13, 2013. The company recorded revenues of $305.8 million during the financial year ended December 2012 (FY2012), an increase of 4.6% over FY2011. The operating profit of the company was $25.6 million in FY2012, a decrease of 27% over FY2011. The net profit was $155 million in FY2012, as compared to a net profit of $30.6 million in FY2011.

Reasons to Purchase:

* Gain understanding of Acorda Therapeutics, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Acorda Therapeutics, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Acorda Therapeutics, Inc.'s business structure, strategy and prospects

Companies Mentioned in this Report: Acorda Therapeutics, Inc.

Partial Table of Contents:

Company Snapshot
Acorda Therapeutics, Inc.: Company Overview
Acorda Therapeutics, Inc.: Overview and Key Facts
Acorda Therapeutics, Inc.: Overview
Acorda Therapeutics, Inc.: Key Facts
Acorda Therapeutics, Inc.: Key Employees
Acorda Therapeutics, Inc.: Key Employee Biographies
Acorda Therapeutics, Inc.: Major Products and Services
Acorda Therapeutics, Inc.: Company History
Acorda Therapeutics, Inc.: Management Statement
Acorda Therapeutics, Inc.: Key Competitors
Acorda Therapeutics, Inc.: Company Analysis
Acorda Therapeutics, Inc.: Business Description
Acorda Therapeutics, Inc.: SWOT Analysis
Acorda Therapeutics, Inc.: SWOT Overview
Acorda Therapeutics, Inc.: Strengths
Acorda Therapeutics, Inc.: Weaknesses
Acorda Therapeutics, Inc.: Opportunities
Acorda Therapeutics, Inc.: Threats
Acorda Therapeutics, Inc.: Corporate Financial Deals Activity
Acorda Therapeutics, Inc.: Financial Deals Overview
Acorda Therapeutics, Inc.: Targets and Partners
Acorda Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Acorda Therapeutics, Inc.: Mergers and Acquisitions
Acorda Therapeutics, Inc.: Partnership
Acorda Therapeutics, Inc.: Recent Developments
Acorda Therapeutics, Inc.: News and Events Summary
Acorda Therapeutics, Inc.: Business Expansion
Acorda Therapeutics, Inc.: Contracts
Acorda Therapeutics, Inc.: Corporate Governance
Acorda Therapeutics, Inc.: Financial Performance
Acorda Therapeutics, Inc.: Grants
Acorda Therapeutics, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Acorda Therapeutics, Inc.: Key Facts
Table 2: Acorda Therapeutics, Inc.: Key Employees
Table 3: Acorda Therapeutics, Inc.: Key Competitors
Table 4: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Acorda Therapeutics, Inc.: M&A Activity by Geography (TTM*)
Table 6: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 7: Acorda Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: Acorda Therapeutics, Inc.: Targets and Partners
Table 9: Acorda Therapeutics, Inc.: Top Deals 2009 - 2013YTD*
Table 10: Acorda Therapeutics, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 11: Acorda Therapeutics, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 12: Acorda Therapeutics, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 13: Acorda Therapeutics, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 14: Acorda Therapeutics, Inc.: News and Events Summary
Table 15: Acorda Therapeutics, Inc.: Business Expansion
Table 16: Acorda Therapeutics, Inc.: Contracts
Table 17: Acorda Therapeutics, Inc.: Corporate Governance
Table 18: Acorda Therapeutics, Inc.: Financial Performance
Table 19: Acorda Therapeutics, Inc.: Grants
Table 20: Acorda Therapeutics, Inc.: Research & Development

List of Figures

Figure 1: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Acorda Therapeutics, Inc.: M&A Activity by Geography (TTM*)
Figure 3: Acorda Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=737349&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser